With results from 445 S&P 500 members already out (91.1% of the index’s total market cap), the third-quarter earnings season is drawing to a close. According to our latest Earnings Trend report, the scorecard so far has portrayed a much better picture with the third quarter successfully emerging as the first to witness earnings growth after five back-to-back quarters of declines for the S&P 500 index. With a handful of earnings announcements on the way, this season has so far confirmed an improving trend.
Total earnings for these 445 companies are up 4% year over year on 2.7% higher revenues, with 72.8% beating earnings estimates and 55.3% exceeding revenue expectations. As per the report, Medical is one of the 12 broader sectors among the 16 Zacks sectors that have reported earnings growth so far. The sector has witnessed 6.4% earnings growth on the back of 7.4% higher revenues in the third quarter.
What’s in Store for the Med-Product Space?
Medical product, a niche area under the medical device subcategory within the broader Medical sector, holds considerable promise at the moment, courtesy of the two-year suspension of the controversial 2.3% medical device excise tax. In addition, the recent change in consumer demand and market dynamics led to a dramatic transformation in the healthcare system. This is evident from the growing prevalence of minimally invasive surgeries, rising demand for liquid biopsy tests, use of IT for ensuring quick and improved patient care, and the shift of the payment system to a value-based model, among others.
Let’s take a look at a few major Medical Product stocks that are slated to release their third-quarter reports on Nov 11:
OmniComm Systems Inc. OMCM: Based in Fort Lauderdale, FL, OmniComm Systems is a leading strategic software solutions provider to the life sciences industry. OmniComm Systems is dedicated toward helping the world’s pharmaceutical, biotechnology; contract research organizations, diagnostic and device firms, and academic medical centers to maximize the value of their clinical research investments.
We cannot conclusively predict a beat for OmniComm Systems as well, as it currently carries a Zacks Rank #3 and an Earnings ESP of 0.00%. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.
BioSig Technologies, Inc. : BioSig Technologiesis based in Minneapolis, MN. It is a medical device company that is developing a proprietary technology platform designed to improve the rapidly growing electrophysiology (EP) marketplace.
BioSig Technologies’ Earnings ESP of 0.00% and Zacks Rank #3 dim possibilities of an earnings beat. You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks' Best Investment Ideas for Long-Term Profit
Today you can gain access to long-term trades with double and triple-digit profit potential rarely available to the public. Starting now, you can look inside our stocks under $10, home run and value stock portfolios, plus more. Want a peek at this private information? Click here >>